Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to ...

Boehringer Ingelheim merges AMAL and ViraTherapeutics cancer units, Dantari sells assets to Adanate, Madrona raises $770M, and Abdera adds JJDC and Foresite as investors.

A new report from Novotech reveals the OV market is expanding at pace, with a compounding annual growth rate of 14.2% between 2019 and 2024. More than 95% of ongoing trials involving oncolytic viruses ...

Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment, ...

As our knowledge of science and the human body expands, so too do doctors have more tools at hand when treating cancer. One ...

Oncolytic Viruses companies are Targovax, Genelux, Imugene, EpicentRx, Replimune, Candel Therapeutics, DNAtrix, CG Oncology, Amgen, Daiichi Sankyo, etc ALBANY, NY ...

Semliki Forest virus was originally isolated from mosquitoes in the Semliki Forest, Uganda, hence the name. Upon systemic infection from mosquito bites, Semliki Forest virus causes mild blood viremia ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a ...

Researchers have identified the gateway for neuro-invasion in Semliki Forest virus infection, potentially enabling it to be ...

Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement with ArriVent BioPharma, Inc. for MRG007, a Potential Best-in-Class antibody- drug ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will participate in the ...